# Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD

> **NCT03012646** · PHASE2 · WITHDRAWN · sponsor: **United Therapeutics**

## Conditions studied

- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Inhaled Treprostinil

## Key facts

- **NCT ID:** NCT03012646
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03012646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03012646, "Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03012646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*